UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012254 |
|---|---|
| Receipt number | R000013500 |
| Scientific Title | A phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic adenocarcinoma |
| Date of disclosure of the study information | 2013/11/09 |
| Last modified on | 2018/11/12 11:32:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/11/08 21:54:52 | ||
| 2 | Update | 2013/11/13 10:27:15 | Key exclusion criteria |
|
| 3 | Update | 2013/11/13 11:50:27 | Key secondary outcomes |
|
| 4 | Update | 2014/01/29 09:08:12 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2014/01/29 10:36:01 | Target sample size |
|
| 6 | Update | 2014/11/10 07:49:39 | Publication of results |
|
| 7 | Update | 2015/05/15 14:01:30 | Date of closure to data entry |
|
| 8 | Update | 2015/11/08 09:12:25 | Recruitment status |
|
| 9 | Update | 2016/05/10 21:10:02 | Control |
|
| 10 | Update | 2016/05/10 21:10:40 | Name of primary person or sponsor Organization |
|
| 11 | Update | 2016/11/12 21:55:55 | Key inclusion criteria |
|
| 12 | Update | 2017/11/11 10:21:22 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 13 | Update | 2018/11/12 11:32:17 | Publication of results |
